“millennium-pharmaceuticals” Archives

in
Entry Author Date Location
Dyno Debuts With Plan, Partnerships for Better Gene Therapy Vectors 05/11/20 Boston
Why Steve Kafka Left Third Rock Ventures for Up-and-Comer Section 32 11/05/19 San Diego
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
After a High-Speed Decade, Agios CEO David Schenkein to Step Aside 09/04/18 Boston
Decibel Hauls in $55M to Bring Multiple Hearing Drugs to the Clinic 06/19/18 Boston
Last Chance to Save on June 21’s ‘New York Biotech: Bringing Back the Expats’ 06/13/18 National
Ahead of June 21 Xconomy Event, NY ‘Expats’ Talk Big Apple’s Biotech Future 06/07/18 National
Stand Up to “Bully” Trump: Bio CEOs Levin, Holtzman Call to Their Peers 08/24/17 Boston
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug 08/01/17 Boston
Checkmate Pharma Clinches $27M for More Studies in Skin Cancer 06/15/17 Boston
Mersana Plans IPO to Finance Clinical Trials for Breast Cancer Drug 06/02/17 Boston
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
Biotech Vet Dunsire’s New Challenge: Grow Tiny Startup, XTuit 03/08/17 Boston
Third Rock Gets $616M to Grow New Crop of Biotech Startups 10/31/16 Boston
Eleven Bio Buys Viventia, Rebrands as Cancer Drug Developer 09/21/16 Boston
Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug 09/07/16 Boston
Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup 06/30/16 Boston
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
After Failed Schizophrenia Trial, Forum Pharma To Shutter This Week 06/27/16 Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
Restructuring Looms for Forum as Neuro Drug Fails Key Clinical Test 03/24/16 Boston
With $75M, Deciphera Fuels Push For Cancer Drugs—And a Future IPO 09/21/15 Boston
Celgene Cozies up to Nurix With $150M Drug Development Deal 09/16/15 San Francisco
Stealthy X4 Pharma, Aided by Termeer, Other Ex-Genzymers, Nabs $37M+ 09/01/15 Boston
Protagonist Nabs $40M, Eyes 1st Trial Of Oral Peptide In Gut Disease 07/16/15 San Francisco
Ex-Pfizer Exec Gutierrez-Ramos to Lead Synlogic’s “Smart Bug” Plan 05/21/15 Boston
Dunsire, Forum Pharma Look Beyond Fidelity For Big Alzheimer’s Push 04/22/15 Boston
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles 03/04/15 Boston
Page 1 of 4 next page »